Tom Collins is a freelance writer in South Florida who has written about medical topics from nasty infections to ethical dilemmas, runaway tumors to tornado-chasing doctors. He travels the globe gathering conference health news and lives in West Palm Beach.
News
Primary care deficient in cancer survivor care
Primary care physicians falling short with cancer survivors.
News
No overall survival benefit from early SIRT for liver metastases from colorectal cancer
“Early use of SIRT in combination with first-line oxaliplatin-based chemotherapy cannot be recommended in unselected patients with metastatic...
News
ASCO issues new guideline on stage IV NSCLC
Use of checkpoint inhibitors recommended for some patients with non–small-cell lung cancer.
News
Study findings cast doubt on community-acquired pneumonia diagnostic practices
Practice changes may be necessary.
News
Obinutuzumab-CHOP not superior to rituximab-CHOP in new DLBCL
Two drug regimens for diffuse large B-cell lymphoma compared in a phase 3 trial.
News
Crizotinib shows responses in pediatric ALCL and IMT
Eighty percent of ALK-positive anaplastic large cell lymphoma patients in the high-dose group had a complete response, along with 83% given the...
News
Allele-matching in cord blood transplant yields better survival
Matching down to the allele level in umbilical cord blood transplantation between unrelated donors results in greater overall survival for those...
News
Blood markers can detect early pancreatic cancer
A test in development is recommended for those at high risk and those newly diagnosed with diabetes.
News
Midostaurin improves survival in new AML
Adding the multitargeted kinase inhibitor midostaurin to standard chemotherapy led to significantly longer overall and event-free survival...
News
Gilteritinib shows safety, efficacy in relapsed/refractory AML
Gilteritinib is attractive because it has in vitro activity against FLT3 internal tandem duplication mutations and tyrosine kinase domain...
News
Two SNPs linked to survival in R-CHOP–treated DLBCL
Use of a patient’s genetics rather than a tumor’s genetic makeup could change lymphoma treatment.
News
Liposomes boost bortezomib efficacy
Liposomes might be able to boost efficacy and reduce side effects of bortezomib.
News
12 things pharmacists want hospitalists to know
From better communications to extra vigilance to high-risk decisions, veteran pharmacists outline areas for improvement.
News
Presenters hand out tips for better handoffs
LAS VEGAS – I-PASS interventions for handoffs can reduce preventable adverse events by 30%.
News
Stump the Professor event entertains, educates
Gurpreet Dhaliwal, MD, professor of medicine at the University of California, San Francisco, joked that participating in a “Stump the Professor”...